Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 540 of 6351
-
New cocktail of drugs aims to fight tough esophageal cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KC1036 in combination with PD-1 antibody and platinum-based chemotherapy as a first-line treatment for patients with unresectable locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma (ESC…
Phase 2 • Sponsor: Beijing Konruns Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for pancreatic cancer: drug cocktail trial launches
Disease control Recruiting nowThis phase II trial tests the safety, side effects and best dose of BMS-986340 in combination with nivolumab, gemcitabine, and nab-paclitaxel and how well it works in treating patients with pancreatic adenocarcinoma that has spread from where it first started (primary site) to ot…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Radioactive One-Two punch takes on returning prostate cancer
Disease control Recruiting nowThis phase II trial compares the use of 225Ac-PSMA-617 to 177Lu-PSMA-617, along with stereotactic body radiotherapy for the treatment of prostate cancer that has come back after a period of improvement (recurrent) and that has spread from where it first started (primary site) to …
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug tofersen under watch for ALS patients in china
Disease control OngoingIn this study, researchers will learn more about the safety of tofersen, also known as Qalsody®. This is a drug available for doctors to prescribe for people with a certain type of amyotrophic lateral sclerosis, also known as ALS. This type is in people who have a mutation in the…
Phase 4 • Sponsor: Biogen • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill may help adults with rare adrenal disorder cut back on steroids
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.
Phase 3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New scan could spot hidden pancreatic cancer spread
Diagnosis Recruiting nowThis is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic disease in individuals with pathologically confirmed pancreatic ductal adenocarcinoma. Following screening, using a standardi…
Phase 3 • Sponsor: SOFIE • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
New pill combo aims to slash cholesterol in High-Risk patients
Disease control OngoingThis study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both as a fixed-dose combination (FDC) with ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering…
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
Promising combo targets rare blood cancer in early trial
Disease control Recruiting nowThe goal of this clinical trial is to study the efficacy of the tagraxofusp + venetoclax combination in treatment-naive blastic plasmacytoid dendritic cell neoplasm adult patients. The main question is to verify the response in patients after 3 cycles of tagraxofusp+venetolax an…
Phase 2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo targets stomach cancer protein in 100-Patient trial
Disease control Recruiting nowThis study examines whether adding the drug Zolbetuximab to an existing treatment (Paclitaxel and Ramucirumab) can improve patients' survival. The goal is to see if this combination works better for patients whose tumours contain a specific protein (CLDN18.2). The results will be…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New COVID vaccine trial targets healthy Middle-Aged adults
Vaccine OngoingThe purpose of this pragmatic randomized trial is to evaluate the vaccine effectiveness of the COVID-19 vaccine, mRNA-1273, in adults aged 50-64 years without known risk factors for severe COVID-19 infection. Participants will be randomized 1:1 to either COVID-19 vaccine or no CO…
Phase 4 • Sponsor: Tor Biering-Sørensen • Aim: Vaccine
Last updated Jun 27, 2026 11:02 UTC
-
AI face scan could spot hidden heart disease
Diagnosis Recruiting nowThis study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are: 1. To verify if the AI algorithm can accur…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New imaging clues could sharpen brain tumor monitoring
Diagnosis Recruiting nowThis trial is a single arm study for patients receiving bevacizumab for IDH-wildtype glioblastoma. Patients receiving bevacizumab (an anti-VEGF therapy) will receive PSMA scans to investigate the role of PSMA expression in glioblastoma and its relationship to VEGF expression.
Sponsor: Royal North Shore Hospital • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New combo therapy aims to outsmart resistant breast cancer
Disease control Recruiting nowThe Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter study evaluating the efficacy, safety, and tolerability of evorpacept in combination with trastuzumab and chemotherapy in participants with HER2-positive metastatic breast cancer who have previously received …
Phase 2 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug cocktail aims to spare bladders in tough cancer
Disease control Not yet recruitingThis is a prospective, open-label, single-center, single-arm clinical study. Plans to enroll 45 MIBC patients with clinical stage T2-T4aN0M0 and HER2-positive (IHC 1+/2+/3+) status. Treatment Flow: Post maximal Transurethral Resection of Bladder Tumor (TURBT); 2 cycles of Gemcita…
Phase 2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug cocktail targets tough lung cancer
Disease control Not yet recruitingThis is an open-label, multicenter, Phase II clinical study designed to evaluate the safety and efficacy of JSKN033 in the treatment of patients with advanced NSCLC. The study is divided into two phases: Part 1 (Dose Selection) and Part 2 (Cohort Expansion). Enrolled subjects are…
Phase 2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for lung cancer patients whose treatment has failed
Disease control Recruiting nowNon-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and change in disease activity of telisotuzumab adizutecan as a monotherapy or in combination with osime…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Robot vs. sonographer: 70,000 women join breast cancer screening showdown
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if robotic ultrasound screening works as well as or better than traditional sonographer-led screening for detecting breast cancer. It will also explore how well participants follow recommended post-screening care. The main questions it …
Sponsor: Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Could a gut bacteria transplant save lungs from sepsis?
Disease control Recruiting nowSepsis is a systemic inflammatory response syndrome triggered by infection, and it is a common critical illness in clinical practice, often leading to multiple organ dysfunction. Among these, acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are among the mos…
Phase 2/3 • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could melatonin help save Babies' brains after birth injury?
Disease control OngoingTo compare the survival rate and improvement in stage of hypoxic ischemic encephalopathy (HIE) at day 7 of treatment in neonates treated with versus without melatonin in addition to standard supportive therapy.
Phase 2 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can community coalitions slash HIV rates in the south?
Prevention By invitation onlyThis study will evaluate a status-neutral integrated strategy to improve access to and uptake of HIV prevention and treatment services for the highest HIV incidence (HHI) men who have sex with men (MSM) in participating communities. The ultimate goal is to establish a strategy to…
Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC